Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jayesh Desai

Showing results (91-100 of 179) with videos related to

Pageof 18
Sort By:
ANZ Journal of Surgery|October 6, 2018
Treatment of patients with primary retroperitoneal sarcoma: predictors of outcome from an Australian specialist sarcoma centreHayden A Snow, Tatiana X Hitchen, Jessica Head, et al.
Investigational New Drugs|April 12, 2018
A multi-arm phase I dose escalating study of an oral NOTCH inhibitor BMS-986115 in patients with advanced solid tumoursKyaw L Aung, Anthony B El-Khoueiry, Karen Gelmon, et al.
Analytical Chemistry|October 6, 2017
On-Line Ion Exchange Liquid Chromatography as a Process Analytical Technology for Monoclonal Antibody Characterization in Continuous BioprocessingBhumit A Patel, Nuno D S Pinto, Adrian Gospodarek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2012
Phase II study of ganitumab, a fully human anti-type-1 insulin-like growth factor receptor antibody, in patients with metastatic Ewing family tumors or desmoplastic small round cell tumorsWilliam D Tap, George Demetri, Phillip Barnette, et al.
International Journal of Cancer|July 17, 2010
Optimizing targeted therapeutic development: analysis of a colorectal cancer patient population with the BRAF(V600E) mutationJeanne Tie, Peter Gibbs, Lara Lipton, et al.
Targeted Oncology|March 15, 2022
The Management of Unresectable, Advanced Gastrointestinal Stromal TumoursTiffany Foo, David Goldstein, Eva Segelov, et al.
NPJ Precision Oncology|November 21, 2025
A signal-seeking phase 2 study of tremelimumab in advanced cancers with high tumour mutational burdenSubotheni Thavaneswaran, Frank Lin, David Espinoza, et al.
JCO Clinical Cancer Informatics|February 22, 2020
CART-WHEEL.org: An Ethically Approved Online Database for Patient-Entered Data to Facilitate Rare Cancer ResearchDamien Kee, Clare Parker, Susie Bae, et al.
Asia-Pacific Journal of Clinical Oncology|April 15, 2015
Novel quality indicators for metastatic colorectal cancer management identify significant variations in these measures across treatment centers in AustraliaNatalie Heather Turner, Hui-Li Wong, Kathryn Field, et al.
Nature Medicine|January 25, 2025
Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: a randomized phase 3 trialScott Kopetz, Takayuki Yoshino, Eric Van Cutsem, et al.
Pageof 18

Showing results (91-100 of 179) with videos related to

Sort By:
Pageof 18
ANZ Journal of Surgery|October 6, 2018
Treatment of patients with primary retroperitoneal sarcoma: predictors of outcome from an Australian specialist sarcoma centreHayden A Snow, Tatiana X Hitchen, Jessica Head, et al.
Investigational New Drugs|April 12, 2018
A multi-arm phase I dose escalating study of an oral NOTCH inhibitor BMS-986115 in patients with advanced solid tumoursKyaw L Aung, Anthony B El-Khoueiry, Karen Gelmon, et al.
Analytical Chemistry|October 6, 2017
On-Line Ion Exchange Liquid Chromatography as a Process Analytical Technology for Monoclonal Antibody Characterization in Continuous BioprocessingBhumit A Patel, Nuno D S Pinto, Adrian Gospodarek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2012
Phase II study of ganitumab, a fully human anti-type-1 insulin-like growth factor receptor antibody, in patients with metastatic Ewing family tumors or desmoplastic small round cell tumorsWilliam D Tap, George Demetri, Phillip Barnette, et al.
International Journal of Cancer|July 17, 2010
Optimizing targeted therapeutic development: analysis of a colorectal cancer patient population with the BRAF(V600E) mutationJeanne Tie, Peter Gibbs, Lara Lipton, et al.
Targeted Oncology|March 15, 2022
The Management of Unresectable, Advanced Gastrointestinal Stromal TumoursTiffany Foo, David Goldstein, Eva Segelov, et al.
NPJ Precision Oncology|November 21, 2025
A signal-seeking phase 2 study of tremelimumab in advanced cancers with high tumour mutational burdenSubotheni Thavaneswaran, Frank Lin, David Espinoza, et al.
JCO Clinical Cancer Informatics|February 22, 2020
CART-WHEEL.org: An Ethically Approved Online Database for Patient-Entered Data to Facilitate Rare Cancer ResearchDamien Kee, Clare Parker, Susie Bae, et al.
Asia-Pacific Journal of Clinical Oncology|April 15, 2015
Novel quality indicators for metastatic colorectal cancer management identify significant variations in these measures across treatment centers in AustraliaNatalie Heather Turner, Hui-Li Wong, Kathryn Field, et al.
Nature Medicine|January 25, 2025
Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: a randomized phase 3 trialScott Kopetz, Takayuki Yoshino, Eric Van Cutsem, et al.
Pageof 18